Global Anti-aging Drugs Market Insights and Forecast to 2027

Botox and filler treatments are into the drift. Botox encompasses purified bacteria that freezes muscles. In doing so, Botox can help minimalize the appearance of wrinkles and lines caused by facial fillers and expressions contain elements that add plumpness to areas that have thinned due to aging.
The industry's leading producers are Allergan, Galderma and LG Life Science, with revenue ratios of 41.40%, 16.45% and 8.36%, respectively, in 2019.

Market Analysis and Insights: Global Anti-aging Drugs Market
The global Anti-aging Drugs market is valued at US$ 7020.4 million in 2019. The market size will reach US$ 15480 million by the end of 2026, growing at a CAGR of 11.9% during 2021-2026.

Global Anti-aging Drugs Scope and Market Size
Anti-aging Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Anti-aging Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

Segment by Type
Dermal Fillers
Botulinum Toxin
Others

Segment by Application
Hospital
Beauty Parlor
Others

By Company
Allergan
Galderma
LG Life Science
Merz Pharma
Medytox
Hugel
IMEIK
Haohai Bio
Daewoong Pharmaceutical
Bloomage
Suneva Medical
SciVision Biotech

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia